Immutep Limited

Healthcare

NASDAQ:IMMP · NASDAQ Global Market

Market Cap $55.15M Beta 2.24 P/E (TTM) -0.9

$0.37 +0.64%

+$0.00 today

52W Low $0.29High $3.53

Vol 0.23M · Avg 13.46M

EPS (TTM) -$0.06Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-75.38%

Period High

$3.18

Period Low

$0.31

Latest

$0.37

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Capricor Therapeutics, Inc.

NASDAQ:CAPR

$1.32B

Achieve Life Sciences, Inc.

NASDAQ:ACHV

$503.11M

Allogene Therapeutics, Inc.

NASDAQ:ALLO

$501.76M

Cabaletta Bio, Inc.

NASDAQ:CABA

$475.30M

Candel Therapeutics, Inc.

NASDAQ:CADL

$463.64M

Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

$351.49M

Entrada Therapeutics, Inc.

NASDAQ:TRDA

$272.13M

Editas Medicine, Inc.

NASDAQ:EDIT

$257.97M

ProQR Therapeutics N.V.

NASDAQ:PRQR

$202.50M

Mereo BioPharma Group plc

NASDAQ:MREO

$51.30M

What is the latest IMMP filing?

The latest filing shown is 6-K dated Jun 5, 2026.

How many recent filings does IMMP have?

Intrinsic Alpha currently shows 20 recent filings for IMMP.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.